A
Apimeds Pharmaceuticals US Inc
AMEX:APUS
Apimeds Pharmaceuticals US Inc
AMEX:APUS
Price:
1.91
USD
17.18%
Market Closed
Market Cap:
$24m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Apimeds Pharmaceuticals US Inc
AMEX:APUS
|
US |
|
B
|
BKS Bank AG
XBER:BK5
|
AT |
|
China Resources Land Ltd
HKEX:1109
|
HK |
Income Statement
Earnings Waterfall
Apimeds Pharmaceuticals US Inc
Apimeds Pharmaceuticals US Inc
Income Statement
Apimeds Pharmaceuticals US Inc
Apimeds Pharmaceuticals US Inc
Currency: USD
| Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|
| Revenue | ||||
| Interest Expense |
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||
| Operating Expenses |
(1)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(0)
|
(1)
|
(1)
|
|
| Research & Development |
(0)
|
(0)
|
0
|
|
| Operating Income |
(1)
N/A
|
(1)
-17%
|
(1)
-71%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(1)
N/A
|
(1)
-16%
|
(1)
-79%
|
|
| Net Income | ||||
| Income from Continuing Operations |
(1)
|
(1)
|
(1)
|
|
| Net Income (Common) |
(1)
N/A
|
(1)
-16%
|
(1)
-79%
|
|
| EPS (Diluted) |
-0.06
N/A
|
-0.07
-17%
|
-0.12
-71%
|
|
Switch to:
Switch to:
See Also
Discover More
